Healthcare veteran Paul Brient, SVP and chief product officer at Athenahealth, talks to MobiHealthNews about what happened in 2020 and makes predictions for the future.

The company is using the new funds to hire more staff in leadership positions.

There was no shortage of variety among the 2020 healthcare initiatives from Alphabet's major business units.

As the agency's workload swells with the weight of a public health emergency, digital health companies on a timeline should consider whether their products truly warrant a regulatory submission, writes Epstein Becker & Green's Bradley Merrill Thompson.

With the platform, Highmark will support patients and clinicians to increase their engagement throughout the healthcare journey.

New report compares symptom assessment apps on condition coverage, accuracy and safety.

Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.

Now available in public preview, the offerings are designed to help organizations and individuals pull clinically-relevant insights from large volumes of free text housed in medical records.

Experts say that designing technology for everyone and creating customization features for smaller populations are key in making better solutions for seniors.

Gearbox Studios CEO Randy Pitchford and videogame science company MMOS cofounder Attila Szantner discuss the design and deployment decisions that drew 1.6 million players to their gene sequencing alignment puzzle game, and how "citizen science" games can help advance data-driven research.

Bradley Merrill Thompson, an FDA-watcher, lawyer and occasional MobiHealthNews guest contributor, joins the MobiHealthNews team for a closer look at what the FDA has been up to around digital health and AI.

The new service lets patients take a digital eye exam and get their prescription renewed by an eye doctor.

Hemant Taneja, managing director of General Catalyst, talks about what tech can learn from health and vice versa.

Panelists at the HIMSS & Health 2.0 European Digital Conference discuss how digital health can help women learn more about their sexual health and wellbeing.

Provider buy-in is more important than ever, digital therapeutics stakeholders say.

Takeaways from Alison Byrne, FGM specialised midwife at Sandwell and West Birmingham NHS trust & University Hospitals Birmingham NHS trust and Lina Chan, founder and CEO of Parla who will be speaking at HIMSS Europe Digital.

Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.

Founded in 2015, Singapore-headquartered digital health company Mobio Interactive announced that it has closed $1.8 million in a seed funding round. The round was led by Singapore-based Verge HealthTech Fund along with Atlas Asset Management, Creative Ventures and VC giant SOSV. Mobio Interactive develops and commercializes clinically validated and objectively quantified software to prevent, measure and treat…

In recent years, we have seen the rise of professional groups centered on digital health and telemedicine and established healthcare organizations release guidelines about health innovation. As tech continues to transform health, these efforts have pushed the conversation around digital health validation, implementation and ethics. This month we are following the efforts of entrepreneurs, doctors, investors and…

The COVID-19 pandemic has accelerated telehealth development in countries around the world, including Italy. In this on-demand session at the HIMSS & Health 2.0 European Digital Conference, Italian healthcare experts reflect on the progress made in digital health.